加《医学邮报》第15卷第25期(1979年)报道:美国一位外科肿瘤学家称,应用雌激素阻滞剂的长期随访工作虽很少,但有些病人的生存时间达7年或7年以上,这些病人在通常情况下将于2年内死亡。丹佛地区的丹佛综合医院外科肿瘤科主任穆尔(George Moore)在加拿大萨斯客彻温的内外科医学院及该地区医学会的联合会上说, Plus, Medical Post, Vol. 15, No. 25 (1979): A surgical oncologist in the United States stated that although there is little long-term follow-up work with estrogen blockers, some patients survive for 7 years. Or more than 7 years, these patients will normally die within 2 years. George Moore, director of surgical oncology at the Denver General Hospital in Denver, said at the University of Saskatchewan’s School of Medicine and Surgery and the Federation of Medical Associations in the region that